Highlight selection of radiochemistry and radiopharmacy developments by editorial board

Review (2022)
Author(s)

Jun Toyohara (Tokyo Metropolitan Institute of Gerontology, Tokyo)

Mohammed Qahtani (King Faisal Specialist Hospital and Research Centre)

Ya Yao Huang (National Taiwan University)

Emiliano Cazzola (Sacro Cuore-Don Calabria Hospital, Negrar)

Sergio Todde (Università degli Studi di Milano Bicocca)

Shozo Furumoto (Tohoku University)

Renata Mikolajczak (National Centre for Nuclear Research (NCBJ), Otwock)

Antonia G. Denkova (TU Delft - RST/Applied Radiation & Isotopes)

Yann Seimbille (Erasmus MC)

Research Group
RST/Applied Radiation & Isotopes
Copyright
© 2022 Jun Toyohara, Mohammed Al-Qahtani, Ya Yao Huang, Emiliano Cazzola, Sergio Todde, Shozo Furumoto, Renata Mikolajczak, A.G. Denkova, Y. Seimbille
DOI related publication
https://doi.org/10.1186/s41181-022-00177-w
More Info
expand_more
Publication Year
2022
Language
English
Copyright
© 2022 Jun Toyohara, Mohammed Al-Qahtani, Ya Yao Huang, Emiliano Cazzola, Sergio Todde, Shozo Furumoto, Renata Mikolajczak, A.G. Denkova, Y. Seimbille
Research Group
RST/Applied Radiation & Isotopes
Issue number
1
Volume number
7
Reuse Rights

Other than for strictly personal use, it is not permitted to download, forward or distribute the text or part of it, without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license such as Creative Commons.

Abstract

Background: The Editorial Board of EJNMMI Radiopharmacy and Chemistry releases a biannual highlight commentary to update the readership on trends in the field of radiopharmaceutical development. Main Body: This commentary of highlights has resulted in 21 different topics selected by each coauthoring Editorial Board member addressing a variety of aspects ranging from novel radiochemistry to first in man application of novel radiopharmaceuticals. Conclusion: Trends in radiochemistry and radiopharmacy are highlighted demonstrating the progress in the research field in various topics including new PET-labelling methods, FAPI-tracers and imaging, and radionuclide therapy being the scope of EJNMMI Radiopharmacy and Chemistry.